SWOT Analysis for Supriya Lifescience Ltd.

Companies with no Debt
High DVM Mid and Small Caps (subscription)
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
Newly Affordable Stocks with Good Financials and Durability (subscription)
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Affordable Stocks with High ROE and Momentum
Companies with high TTM EPS Growth
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing profits every quarter for the past 4 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge

Increasing Trend in Non-Core Income
Top Losers
Sell Zone: Stocks in the sell zone based on days traded at current PE and P/BV
Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months

MFs decreased their shareholding last quarter
Insiders sold stocks

High Piotroski Score - Companies with strong financials
Stocks with improving cash flow, with good durability
High Piotroski Score with High Return on Equity (ROE) and EPS Growth
Average Affordability - Stocks with Medium Trendlyne Valuation Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Supriya Lifescience Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats